Servier Beats NHS' £220M Drug IP Suit At Top UK Court

By Bonnie Eslinger (July 2, 2021, 10:36 AM BST) -- Britain's highest court ruled on Friday that the government cannot seek £220 million ($300 million) from Servier Laboratories for allegedly making misrepresentations to Europe's intellectual property office and England's courts that blocked generic versions of its blood-pressure drug....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!